The nutrigenomics market is set to reach US$ xx Mn by 2026 from US$ xx Mn in 2017, portraying excellent growth with a compounded annual growth rate (CAGR) of 16.3% during the forecast period from 2018 to 2026. According to the statistics provided by the World Health Organization (WHO), by 2020, chronic diseases will be responsible for 73% of the total global deaths associated with obesity, diabetes, cardiovascular complications, and cancer. Technological advancements in the IT healthcare segment and DNA quantification techniques have a positive impact on the nutrigenomics market's growth. The limitations associated with this market are the dearth of trained healthcare professionals and bacterial contamination associated with saliva and buccal swab collection methods.
Market Synopsis
Rampant growth in clinical laboratories and the availability of a diverse range of test kits drive the reagents and kits market.
Reagents and kits are currently leading the product segment for the nutrigenomics market. The key features responsible for the magnificent growth of reagents and kits are the rampant growth of clinical laboratories and rising public health awareness regarding chronic diseases. Services will garner impressive growth during the forecast period on account of rapidly growing IT healthcare services such as electronic health records of patients (EHR) and user-friendly portable healthcare apps for ailing patients.
Increasing demand for fast food and an unhealthy lifestyle are responsible for the rapid growth of obesity throughout the globe.
Obesity is currently dominating the application segment of the nutrigenomics market. Engineered junk food, insulin resistance, leptin resistance, stress, sedentary lifestyle, and other factors are to blame for the world's rapidly increasing obesity. Arduous research studies have linked genetic factors with obesity, and nutrigenomics is helpful in finding alternatives to fight the socio-economic burden associated with obesity. Nutrigenomics is considered a personalized therapy wherein nutritional requirements vary according to individuals. Chronic disease will see significant growth as a result of factors such as poor nutrition in the daily diet and an unhealthy lifestyle, which cause genetic anomalies, eventually constructing the disease etiology related to chronic disease.
Buccal swabs are the most commonly used test due to their quick, non-invasive nature and the lack of pain associated with sample collection.
The study of nutrigenomics is highly dependent on the DNA sample collected from the patient. Buccal swabs and blood samples are being used for collecting the DNA; the only difference lies in how they are processed while studying the nutrigenomics of a patient. Buccal swab kits are available in diverse varieties, where the consumer can personally extract DNA-rich cells using the buccal swabs, place them in a dry, sterile container, and directly ship them to the concerned laboratories.
This method is very quick, non-invasive, and less painful. Scientists are finding innovative ways to prevent the effect of bacterial contamination in buccal swabs, which reduces the stability of the DNA in the collected sample. Blood samples are the most traditional and reliable method of collecting DNA samples. Venipuncture and the pain associated with sample collection make them less popular in comparison to other collection methods. Other non-invasive methods, such as hair and urine samples, are gaining popularity due to their lower sample volume requirement, good storage, and DNA quantification ability compared to the polymerase chain reaction (PCR) method.
Sedentary lifestyles and increasing public health awareness are responsible for the growth of the nutrigenomics market in North America.
In the current scenario, North America, with a share of 40%, is leading the regional segment for the nutraceuticals market. The factors responsible for the growth of the nutrigenomics market in North America are sedentary lifestyles that give rise to chronic diseases such as obesity and diabetes. Increasing public health awareness and the presence of well-developed nutrition science and health departments drive the nutrigenomics market in North America. According to the latest research cited by the European Center for Disease Control and Prevention (ECDC), 85% of all the deaths recorded in the region are due to chronic diseases such as diabetes, cardiovascular disease, cancer, etc.
Government healthcare agencies have formed strategic alliances with academia and research centers to improve the quality of nutrition in the daily diet in order to decrease the burden associated with chronic diseases. Due to the rising prevalence of chronic disease, malnutrition, and poverty, Asia Pacific will experience significant growth from 2018 to 2026. Government healthcare agencies are fighting to curb malnutrition and provide a nutritional diet to the poverty-stricken population. Traditional herbs and medicines are being studied thoroughly in order to extract their active ingredients to fight chronic diseases.
Periods of History and Forecast
This research report presents the analysis of each segment from 2016 to 2026, considering 2017 as the base year for the research. The compound annual growth rate (CAGR) for each of the respective segments is calculated for the forecast period from 2018 to 2026.
Report Scope by Segments
For the scope of the report, the market is segmented as follows:
Pharmaceutical companies providing reagents and kits to determine the nutrigenomics of human beings are Cura Integrative Medicine, Centogene, Genomix Nutrition, Inc., Metagenics, Inc., NutraGene, Nutrigenomix, Navigenics, XCODE Life Sciences, Pvt. Ltd., WellGen, Inc., and 23andMe, Inc.
Key questions are answered in this report.
How are market assessments performed and current market trends determined?
Who are the leading players providing nutrigenomics reagents and kits?
Which is the largest and fastest-growing product segment for the nutrigenomics market?
Which is the largest and fastest-growing application segment for the nutrigenomics market?
Which is the largest and fastest-growing test segment for the nutrigenomics market?
Which is the largest and fastest-growing geographical segment for the nutrigenomics market?
Frequently Asked Questions:
The market for Nutrigenomics Market is expected to reach US$ XX Mn by 2026.
The Nutrigenomics Market is expected to see significant CAGR growth over the coming years, at 16.3%.
The report is forecasted from 2018-2026.
The base year of this report is 2017.
Cura Integrative Medicine, Centogene, Genomix Nutrition, Inc., Metagenics, Inc., NutraGene, Nutrigenomix, Navigenics, XCODE Life Sciences, Pvt. Ltd., WellGen, Inc., and 23andMe, Inc. are some of the major players in the global market.
